Literature DB >> 9237929

Regulation of B-cell commitment to plasma cells or to memory B cells.

Y J Liu1, J Banchereau.   

Abstract

During humoral immune responses, B-lymphocyte activation is followed by differentiation along either the plasma cell pathway or the memory B-cell pathway. Recent studies suggest that CD40-CD40 ligand, OX-OX40 ligand, a group of cytokines and intracellular transcriptional factors may all contribute to B-lymphocyte differentiation control.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9237929     DOI： 10.1006/smim.1997.0080

Source DB:  PubMed          Journal:  Semin Immunol        ISSN： 1044-5323            Impact factor:   11.130


  19 in total

1.  Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Shaw M Akula; George Sigounas; Yash P Kataria; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

Review 2.  Cellular choreography in the germinal center: new visions from in vivo imaging.

Authors:  Anja E Hauser; Steven M Kerfoot; Ann M Haberman
Journal:  Semin Immunopathol       Date:  2010-07-09       Impact factor: 9.623

Review 3.  Heat-labile enterotoxins as adjuvants or anti-inflammatory agents.

Authors:  Shuang Liang; George Hajishengallis
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

4.  CD46-induced human Treg enhance B-cell responses.

Authors:  Anja Fuchs; John P Atkinson; Veronique Fremeaux-Bacchi; Claudia Kemper
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

5.  Reactive oxygen species play roles on B cell surface receptor CD40-mediated proximal and distal signaling events: effects of an antioxidant, N-acetyl-L-cysteine treatment.

Authors:  Jong Ran Lee
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

6.  Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.

Authors:  Sunil Kannanganat; Bill G Kapogiannis; Chris Ibegbu; Lakshmi Chennareddi; Paul Goepfert; Harriet L Robinson; Jeffrey Lennox; Rama Rao Amara
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

7.  Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus.

Authors:  M Odendahl; R Keitzer; U Wahn; F Hiepe; A Radbruch; T Dörner; R Bunikowski
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

8.  Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model.

Authors:  A Joseph; K Munroe; M Housman; R Garman; S Richards
Journal:  Clin Exp Immunol       Date:  2008-02-25       Impact factor: 4.330

9.  A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.

Authors:  Hava Ben-David; Amir Sharabi; Reshmi Parameswaran; Heidy Zinger; Edna Mozes
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

10.  Defective regulatory B-cell compartment in patients with immune thrombocytopenia.

Authors:  Xiaojuan Li; Hui Zhong; Weili Bao; Nayla Boulad; Jessie Evangelista; Muhammad Anis Haider; James Bussel; Karina Yazdanbakhsh
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.